Advertisement
Screener

BIODESIX, INC. (BDSX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

BIODESIX, INC. Cash Flow Breakdown

Cash flow breakdown shows where BIODESIX, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $23.27M went out.
  • Fiscal year ended 2025-12-31: from investing, $403.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $16.42M came in.
  • Fiscal year ended 2025-12-31: change in cash, $7.26M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldOtherNot split outChange in cash
2025-12-31-$23.27M-$403.00K-$21.00K$7.32M-$817.00K$9.94M*-$7.26M
2024-12-31-$48.65M-$3.44M-$51.00K$55.63M-$445.00K-$3.08M*-$39.00K
2023-12-31-$22.87M-$23.06M-$49.00K$28.13M-$188.00K$1.24M*-$16.80M
2022-12-31-$44.97M-$3.53M-$28.60M$59.54M-$33.00K$27.98M*$10.38M
2021-12-31-$28.22M-$2.55M-$45.43M$16.34M$30.35M*-$29.51M
2020-12-31-$21.37M-$2.93M$1.34M-$6.00K$79.80M*$56.84M
2019-12-31-$21.73M-$1.87M$47.00K-$116.00K$23.04M*-$626.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldOtherNot split outChange in cash
2026-06-30-$1.56M*-$254.00K*-$1.00K*$6.67M*-$153.00K*
2026-03-31-$10.17M-$144.00K-$5.00K$17.21M-$158.00K$6.58M
2025-12-31$778.00K*-$104.00K*-$5.00K*$2.32M*-$262.00K*
2025-09-30-$8.88M*-$67.00K*-$4.00K*-$167.00K*$4.99M*
2025-06-30-$6.57M*-$95.00K*-$5.00K*-$190.00K*$9.98M*
2025-03-31-$8.60M-$137.00K-$7.00K-$198.00K-$8.64M
2024-12-31-$4.10M*-$884.00K*-$13.00K*$0.00*-$169.00K*
2024-09-30-$10.67M*-$286.00K*-$13.00K*$0.00*-$126.00K*
2024-06-30-$18.57M*-$2.00M*-$12.00K*$55.00M*-$80.00K*-$3.61M*
2024-03-31-$15.31M-$273.00K-$13.00K$625.00K-$70.00K-$14.79M
2023-12-31-$12.28M*-$3.00M*-$13.00K*$12.81M*-$61.00K*$8.99M*
2023-09-30-$3.84M*-$5.88M*-$12.00K*$3.00K*-$48.00K*$12.21M*
2023-06-30$937.00K*-$6.47M*-$12.00K*$81.00K*-$45.00K*-$2.35M*
2023-03-31-$7.69M-$7.71M-$12.00K$6.00K-$34.00K-$2.38M*-$17.81M
2022-12-31-$11.95M*-$1.99M*-$23.57M*$41.57M*-$9.00K*
2022-09-30-$10.33M*-$815.00K*-$2.01M*$1.83M*-$9.00K*
2022-06-30-$9.59M*-$380.00K*-$3.01M*$14.54M*-$9.00K*$10.62M*
2022-03-31-$13.10M-$352.00K-$11.00K$1.60M-$6.00K-$4.42M*-$16.29M
2021-12-31-$10.20M*-$641.00K*-$20.00M*$30.00K*$15.61M*
2021-09-30-$7.79M*-$1.04M*-$5.00K*$60.00K*
2021-06-30$1.09M*-$348.00K*-$3.00K*$204.00K*
2021-03-31-$11.33M-$516.00K-$25.42M$30.00M$475.00K-$6.89M
2020-12-31-$8.76M*-$543.00K*$1.31M*$4.00K*$63.76M*
2020-09-30-$3.77M*-$1.57M*$14.00K*-$5.00K*
2020-06-30-$4.30M*-$426.00K*$0.00*$9.63M*
2020-03-31-$4.54M-$392.00K$6.41M$11.00K$1.49M
2019-12-31-$5.73M*-$878.00K*$2.00K*-$102.00K*$3.04M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45